PGR and breast carcinoma: Overall, these date indicate that rs1800686 and rs3765459 polymorphisms are associated with the ER, PR, C-erbB2 and P53 statuses in breast cancer patients, whereas the rs1883832 and rs4810485 polymorphisms may be involved in breast cancer lymph node metastasis.